Official ESCRS | European Society of Cataract & Refractive Surgeons
Vienna 2018 Delegate Registration Programme Exhibition Virtual Exhibition Satellites 2018 Survey


escrs app advert


Search Title by author or title

OMNI 360™ in open-angle glaucoma treatment: a 6 month follow-up

Poster Details

First Author: I.Grabska - Liberek POLAND

Co Author(s):    J. Majszyk - Ionescu   A. Skowyra   M. Rogowska   A. Plichta   P. Duda   I. Kane     

Abstract Details


To analyze the safety and efficacy of the OMNI TM surgical procedure in reducing intraocular pressure (IOP) and the number of glaucoma medications in adult subjects with open-angle glaucoma (OAG).


Department of Ophthalmology, Medical Center of Postgraduate Education, Warsaw, Poland


In a single-surgeon prospective clinical study, 10 eyes of 9 OAG patients underwent OMNI TM surgery. Four eyes of 3 patients underwent OMNI TM alone, and 6 eyes of 6 patients underwent OMNI TM combined with cataract surgery. All patients will have been followed-up for 6 months at the time of presentation. Changes in intraocular pressure (IOP), intraoperative, and postoperative complications will be examined and recorded. Success is defined as post-operative IOP reduction ≥ 20%, from a baseline without glaucoma medications ("complete success") or with topical treatment ("qualified success"). The number of medications before and after surgery will be considered.


Two males and 7 females with a mean age of 74.9 (range 65–87 years), underwent the OMNI TM surgery. The preoperative mean IOP was 18.40 ±6.02 mmHg. The postoperative IOP decreased to a mean of 12.35±3.37, 12.30±3.83, and 13.37±3.42 at 1 week, 1 month and 2 months, respectively. The number of antiglaucoma medications dropped from a mean of 3.15 preoperatively to 0.00, 0.00 and 0.25 at 1 week, 1 month and 2 months, respectively. Complications were: IOP-spikes (five patients), hyphema (six cases) and fibrin in the anterior chamber (one case) that resolved within one week.


The OMNI TM is a promising approach for the treatment of open-angle glaucoma. The procedure achieves reduction of the intraocular pressure and number of glaucoma medications. It also demonstrates a good safety profile. The main advantages of the procedure are: a short surgical learning curve, performance speed, no implants or sutures, ability to be combined with cataract surgery, and no incisions in conjunctiva or sclera.

Financial Disclosure:

is employed by a for-profit company with an interest in the subject of the presentation

Back to Poster listing